Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Continuation Riluzole in the Prevention of Relapse Following Ketamine in Major Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00419003

Organisation Name: Baylor College of Medicine

Overal Status: Completed

Start Date: December 2006

Last Update: July 31, 2019

Lead Sponsor: Baylor College of Medicine

Brief Summary: This study is examining the safety and effectiveness of two medications, ketamine and riluzole, in treating patients with treatment resistant major depressive disorder. This study will also examine the effectiveness of an FDA approved drug called lamotrigine in decreasing the potential side effects associated with ketamine.

Conditions:
  • Major Depression


Total execution time in seconds: 1.4271669387817